Notice: Prescription Drug List (PDL): Triamcinolone acetonide
Description
The purpose of this Notice of Intent to Amend is to notify that, as a result of consultation, Health Canada will revise the listing for Adrenocortical hormones on the Prescription Drug List (PDL) to exempt Triamcinolone acetonide.
Resources
| Name |
Format |
Description |
Link |
| Notice: Prescription Drug List (PDL): Triamcinolone acetonide |
HTML |
|
https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notice-triamcinolone-acetonide-2.html |
| Notice: Prescription Drug List (PDL): Triamcinolone acetonide |
HTML |
|
https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/medicaments/liste-drogues-ordonnance/avis-liste-acetonide-triamcinole-2.html |